0001209191-21-007925.txt : 20210204
0001209191-21-007925.hdr.sgml : 20210204
20210204201844
ACCESSION NUMBER: 0001209191-21-007925
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210203
FILED AS OF DATE: 20210204
DATE AS OF CHANGE: 20210204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FLUKE JOHN M JR
CENTRAL INDEX KEY: 0001191906
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39503
FILM NUMBER: 21592951
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athira Pharma, Inc.
CENTRAL INDEX KEY: 0001620463
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 453368487
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: (206) 221-8112
MAIL ADDRESS:
STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
FORMER COMPANY:
FORMER CONFORMED NAME: M3 Biotechnology, Inc.
DATE OF NAME CHANGE: 20140924
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-03
0
0001620463
Athira Pharma, Inc.
ATHA
0001191906
FLUKE JOHN M JR
C/O ATHIRA PHARMA, INC.
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL
WA
98011
1
0
0
0
Common Stock
2021-02-03
4
M
0
25220
1.19
A
140101
D
Common Stock
2021-02-03
4
M
0
3783
1.35
A
143884
D
Common Stock
6731
I
By Fluke Capital Management, L.P.
Stock Option (Right to Buy)
1.19
2021-02-03
4
M
0
25220
0.00
D
2027-12-12
Common Stock
25220
0
D
Stock Option (Right to Buy)
1.35
2021-02-03
4
M
0
3783
0.00
D
2030-01-28
Common Stock
3783
0
D
This filing relates to the exercise of stock options. No shares of Common Stock were sold by Mr. Fluke, and the shares of Common Stock received upon exercise of the stock options are subject to lock-up agreements with Goldman Sachs & Co. LLC and Jefferies LLC.
The shares subject to the option fully vested on December 13, 2020.
The shares subject to the option fully vested on December 13, 2019.
Glenna Mileson, attorney-in-fact on behalf of John M. Fluke, Jr.
2021-02-04